IP Library Granted Patent US 8,940,740
Granted Patent B2
US 8,940,740 · App. 13/284,609 · Granted Jan 27, 2015

Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification

Inventors: Ashish K. Pathak (Birmingham, AL); Jorge A. Benitez (Atlanta, GA); Anisia J. Silva-Benitez (Atlanta, GA)
Assignee: Southern Research Institute
A61K31/5377
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,740
App. No.
13/284,609
Granted
Jan 27, 2015
Kind
B2
Abstract

Certain compounds are provided that can selectively inhibit motile bacteria such as V. cholerae motility. These compounds can indirectly diminish production of cholera toxin and other major virulence required by the cholera bacterium to cause disease.

Claims (9)

1. A method for inhibiting motility of a Vibrio cholerae which comprises contacting the Vibrio cholerae with an effective amount of a compound selected from the group consisting of at least one compound selected from the group consisting of at least one compound represented by the following formulae:

and pharmaceutically acceptable salt thereof, solvate thereof, prodrug thereof and mixtures thereof.

2. A method for treating a patient by inhibiting motility of Vibrio cholerae in a patient exposed to the Vibrio cholerae which comprises administering to the patient an effective amount of a compound selected from the group consisting of at least one compound represented by the following formulae:

and pharmaceutically acceptable salt thereof, solvate thereof, prodrug thereof and mixtures thereof.

3. A method for the prophylaxis treatment of a cholera outbreak due to the Vibrio cholerae by administering to a patient in danger of exposure to the Vibrio cholerae at least one compound selected from the group consisting of at least one compound represented by the following formulae:

and pharmaceutically acceptable salt thereof, solvate thereof, prodrug thereof and mixtures thereof.

4. The method according to claim 1 wherein said compound is

5. The method according to claim 2 wherein said compound is

6. The method according to claim 3 wherein said compound is

Assignments (2)
CONFIRMATORY LICENSE Recorded May 24, 2024
From: SOUTHERN RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 067516/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2011
From: PATHAK, ASHISH K.; BENITEZ, JORGE A.; SILVA-BENITEZ, ANISIA J.
To: SOUTHERN RESEARCH INSTITUTE
Reel/Frame 027370/0548 →
Continuity (2)
Provisional Application 61407695 · Oct 28, 2010
Related Publication 20120108615A1 · May 3, 2012